Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01817361 · ClinicalTrials.gov registry record
Oral Health and People With Systemic Sclerosis
A clinical trial of Systemic Sclerosis, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 210
- Enrollment target
- 1
- Study location
NCT01817361: Completed study of Systemic Sclerosis, sponsored by University of Alabama at Birmingham.
NCT01817361 is a study of Systemic Sclerosis that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 210 participants, below the 271-participant average among 26 other Systemic Sclerosis trials with a reported enrollment target (23% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01817361, a study of Systemic Sclerosis, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 210 participants
- Enrollment target
- 1
- Study location
Study Summary
The public health impact of this study will be the application of the greater understanding of the oral health status, oral health related behaviors, and quality of life of patients with systemic sclerosis (scleroderma or SSc). It is hoped that risks and protective factors can be identified to be associated with the oral health status of adults with systemic sclerosis,leading to the development of interventions for improved oral health in this population,and providing the basis for a larger study of oral health problems of adults with systemic sclerosis.
Primary Outcome
Periodontal disease will be measured by the loss of attachment of 4mm or more at one or more sites. The number of subjects presenting with periodontal disease will be reported.
Conditions Studied
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2007-10 |
| Est. Completion | 2010-06 |
What the finished NCT01817361 record still lists
NCT01817361 is an observational study that tracks outcomes without assigning an intervention. The registered 210 participants enrollment target is mid-sized for trials with a published cap, below the 271-participant average among 26 other Systemic Sclerosis trials with a reported enrollment target (23% lower).
The record links to 1 condition, with Systemic Sclerosis appearing as the primary indexed condition, and to 0 interventions.
NCT01817361 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT01817361 about?
NCT01817361 is a clinical study titled "Oral Health and People With Systemic Sclerosis". The public health impact of this study will be the application of the greater understanding of the oral health status, oral health related behaviors, and quality of life of patients with systemic sclerosis (scleroderma or SSc). It is hoped that risks and protective factors can be identified to be as...
What is the current status of trial NCT01817361?
This trial is currently completed. The enrollment target is 210 participants. The study started on 2007-10. Estimated completion is 2010-06.
What conditions does trial NCT01817361 study?
This clinical trial studies the following conditions: Systemic Sclerosis.
Who is sponsoring clinical trial NCT01817361?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01817361 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Systemic Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01817361's enrollment target sits among peer trials
210 5th of 26 higher than 22 of 26 other Systemic Sclerosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Systemic Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
RECRUITING · Phase 2
-
Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis
RECRUITING · NA
-
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
RECRUITING · Phase 1
-
A Study of AZD0120 in Autoimmune Diseases
RECRUITING · Phase 1
-
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
RECRUITING · Phase 1
-
New Orleans Pulmonary Hypertension Biobank
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02665923 · 210 participants
Gastric Emptying in Neonates and Infants After Formula Feeding
- NCT03322891 · 210 participants · NA
Improving Health Literacy in African-American Prostate Cancer Patients
- NCT03544489 · 210 participants · Phase 2
Effectiveness of Exercise After an ICD
- NCT04408430 · 210 participants · NA
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia